Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Knop

Showing results (171-180 of 509) with videos related to

Pageof 51
Sort By:
Frontiers in Physiology|May 10, 2019
Glucagon Receptor Signaling and Lipid MetabolismKatrine D Galsgaard, Jens Pedersen, Filip K Knop, et al.
American Journal of Physiology. Endocrinology and Metabolism|December 13, 2023
An extended minimal model of OGTT: estimation of α- and β-cell dysfunction, insulin resistance, and the incretin effectVijaya Subramanian, Jonatan I Bagger, Vinayak Harihar, et al.
Journal of Diabetes and Its Complications|February 28, 2017
Bile acid sequestrants for glycemic control in patients with type 2 diabetes: A systematic review with meta-analysis of randomized controlled trialsMorten Hansen, David P Sonne, Kristian H Mikkelsen, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 17, 2014
Clearance of glucoregulatory peptide hormones during haemodialysis and haemodiafiltration in non-diabetic end-stage renal disease patientsMorten B Jørgensen, Thomas Idorn, Filip K Knop, et al.
Expert Opinion on Pharmacotherapy|February 8, 2019
The efficacy and safety of exenatide once weekly in patients with type 2 diabetesSebastian M Heimbürger, Andreas Brønden, Nicklas J Johansen, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 6, 2021
Pancreatic polypeptide: A potential biomarker of glucose-dependent insulinotropic polypeptide receptor activation in vivoSimon Veedfald, Natasha C Bergmann, Tina Vilsbøll, et al.
Peptides|November 5, 2019
GIP's involvement in the pathophysiology of type 2 diabetesMikkel B Christensen, Lærke S Gasbjerg, Sebastian M Heimbürger, et al.
Metabolism: Clinical and Experimental|June 11, 2016
Vagotomy and subsequent development of diabetes - A nested case-control studyJakob Starup-Linde, Michael Gejl, Per Borghammer, et al.
Peptides|April 24, 2024
Intestinal expression profiles and hepatic expression of LEAP2, ghrelin and their common receptor, GHSR, in humansAnders Englund, Hannah Gilliam-Vigh, Malte P Suppli, et al.
Diabetes, Obesity & Metabolism|November 7, 2023
Greater time spent with HbA1c less than 7.0% with oral semaglutide versus oral comparators: An exploratory analysis of the PIONEER studiesJulio Rosenstock, Bertrand Cariou, Johanna Eliasson, et al.
Pageof 51

Showing results (171-180 of 509) with videos related to

Sort By:
Pageof 51
Frontiers in Physiology|May 10, 2019
Glucagon Receptor Signaling and Lipid MetabolismKatrine D Galsgaard, Jens Pedersen, Filip K Knop, et al.
American Journal of Physiology. Endocrinology and Metabolism|December 13, 2023
An extended minimal model of OGTT: estimation of α- and β-cell dysfunction, insulin resistance, and the incretin effectVijaya Subramanian, Jonatan I Bagger, Vinayak Harihar, et al.
Journal of Diabetes and Its Complications|February 28, 2017
Bile acid sequestrants for glycemic control in patients with type 2 diabetes: A systematic review with meta-analysis of randomized controlled trialsMorten Hansen, David P Sonne, Kristian H Mikkelsen, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 17, 2014
Clearance of glucoregulatory peptide hormones during haemodialysis and haemodiafiltration in non-diabetic end-stage renal disease patientsMorten B Jørgensen, Thomas Idorn, Filip K Knop, et al.
Expert Opinion on Pharmacotherapy|February 8, 2019
The efficacy and safety of exenatide once weekly in patients with type 2 diabetesSebastian M Heimbürger, Andreas Brønden, Nicklas J Johansen, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 6, 2021
Pancreatic polypeptide: A potential biomarker of glucose-dependent insulinotropic polypeptide receptor activation in vivoSimon Veedfald, Natasha C Bergmann, Tina Vilsbøll, et al.
Peptides|November 5, 2019
GIP's involvement in the pathophysiology of type 2 diabetesMikkel B Christensen, Lærke S Gasbjerg, Sebastian M Heimbürger, et al.
Metabolism: Clinical and Experimental|June 11, 2016
Vagotomy and subsequent development of diabetes - A nested case-control studyJakob Starup-Linde, Michael Gejl, Per Borghammer, et al.
Peptides|April 24, 2024
Intestinal expression profiles and hepatic expression of LEAP2, ghrelin and their common receptor, GHSR, in humansAnders Englund, Hannah Gilliam-Vigh, Malte P Suppli, et al.
Diabetes, Obesity & Metabolism|November 7, 2023
Greater time spent with HbA1c less than 7.0% with oral semaglutide versus oral comparators: An exploratory analysis of the PIONEER studiesJulio Rosenstock, Bertrand Cariou, Johanna Eliasson, et al.
Pageof 51